Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMMEDIATE-MI: Early PCSK9 Inhibitor in Acute Myocardial Infarction
NCT07208006Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised trial in acute myocardial infarction (AMI) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Major Adverse Cardiovascular Events at 12 months. Started Jan 2026; status: recruiting.
02
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT07208006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07208006.